Mutations in PSEN1 have been implicated in atypical Alzheimer’s disease (AD) and non-AD phenotypes, including frontotemporal lobar degeneration (FTD), Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and spastic paraplegia (SP) (43). Here, PSEN1 is linked to Spastic paraplegia.